Vascular Access Considerations for Therapeutic Apheresis Procedures

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 140-144

  Okafor, Chidi ^a   Kalantarinia, Kambiz ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APHERESIS; ARTERIOVENOUS FISTULA; ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INDWELLING CATHETER; KIDNEY FAILURE; LONG TERM CARE; MALE; METHODOLOGY; MYASTHENIA GRAVIS; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADULT; ARTERIOVENOUS FISTULA; ATTITUDE OF HEALTH PERSONNEL; BLOOD COMPONENT REMOVAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; LONG-TERM CARE; MALE; MYASTHENIA GRAVIS; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84858698195     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01024.x     Document Type: Article

References (13)

1. Bambauer R: Vascular access in apheresis. Ther Apher Dial 7:145-146, 2003
2. Stegmayr B, Wikdahl AM: Access in therapeutic apheresis. Ther Apher Dial 7:209-214, 2003
3. Bambauer R: Vascular access in apheresis: part II. Ther Apher Dial 7:495-496, 2003
4. Malchesky PS, Koo AP, Skibinski CI, Hadsell AT, Rybicki LA: Apheresis technologies and clinical applications: the 2007 International Apheresis Registry. Ther Apher Dial 14:52-73, 2010
5. Hansberry MR, Whittier WL, Krause MW: The elderly patient with chronic kidney disease. Adv Chronic Kidney Dis 12:71-77, 2005
6. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N: Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 364:303-312, 2011
7. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 16:1449-1455, 2005
8. Schon D, Blume SW, Niebauer K, Hollenbeak CS, de Lissovoy G: Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol 2:268-276, 2007
9. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60:1443-1451, 2001
10. Clinical practice guidelines for vascular access. Am J Kidney Dis 48(Suppl. 1):S176-S247, 2006
11. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA: Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 60:1164-1172, 2001
12. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al.: Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83-177, 2010
13. Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA: Introduction and overview of therapeutic apheresis. J Clin Apher 25:240-249, 2010